Earnings Feed
Start Free
Home/Filings/4/0001225208-11-011470
4//SEC Filing

BERTHIAUME DOUGLAS A 4

Accession 0001225208-11-011470

CIK 0000732485other
View on SEC.govCompany Profile

Filed

Apr 5, 8:00 PM ET

Accepted

Apr 6, 8:24 PM ET

Size

108.5 KB

Accession

0001225208-11-011470

Insider Transaction Report

Form 4
Period: 2011-04-04
GENZYME CORPGENZ
BERTHIAUME DOUGLAS A
Director
Transactions
  • Exercise/Conversion

    Genzyme common stock (GENZ)

    2011-04-04+318.328→ 79,114.319 total
  • Exercise/Conversion

    Genzyme common stock (GENZ)

    2011-04-04+292.752→ 79,721.767 total
  • Exercise/Conversion

    Genzyme common stock (GENZ)

    2011-04-04+286.498→ 80,008.265 total
  • Exercise/Conversion

    Genzyme common stock (GENZ)

    2011-04-04+224.025→ 81,754.653 total
  • Exercise/Conversion

    Genzyme common stock (GENZ)

    2011-04-04+208.531→ 82,174.305 total
  • Disposition to Issuer

    Genzyme common stock (GENZ)

    2011-04-04$74.00/sh−2,375$175,750→ 80,163.86 total
  • Disposition to Issuer

    Genzyme common stock (GENZ)

    2011-04-04$76.01/sh−9,005.86$684,535→ 71,158 total
  • Disposition from Tender

    Genzyme common stock (GENZ)

    2011-04-04$74.00/sh−71,158$5,265,692→ 0 total
  • Exercise/Conversion

    Phantom Stock

    2011-04-04−254.772→ 0 total
    From: 2005-03-31Exp: 2034-12-31→ Genzyme common stock (GENZ) (254.772 underlying)
  • Exercise/Conversion

    Phantom Stock

    2011-04-04−211.121→ 0 total
    From: 2006-03-31Exp: 2034-12-31→ Genzyme common stock (GENZ) (211.121 underlying)
  • Exercise/Conversion

    Phantom Stock

    2011-04-04−286.498→ 0 total
    From: 2007-03-31Exp: 2034-12-31→ Genzyme common stock (GENZ) (286.498 underlying)
  • Exercise/Conversion

    Phantom Stock

    2011-04-04−445.149→ 0 total
    From: 2006-12-31Exp: 2034-12-31→ Genzyme common stock (GENZ) (445.149 underlying)
  • Exercise/Conversion

    Phantom Stock

    2011-04-04−322.9→ 0 total
    From: 2010-12-31→ Genzyme common stock (GENZ) (322.9 underlying)
  • Disposition to Issuer

    Stock Option (right to buy)

    2011-04-04$53.47/sh−18,000$962,460→ 0 total
    Exercise: $53.47From: 2002-05-31Exp: 2011-05-31→ Genzyme common stock (GENZ) (18,000 underlying)
  • Exercise/Conversion

    Genzyme common stock (GENZ)

    2011-04-04+368.937→ 78,473.091 total
  • Exercise/Conversion

    Genzyme common stock (GENZ)

    2011-04-04+2,375→ 73,533 total
  • Exercise/Conversion

    Genzyme common stock (GENZ)

    2011-04-04+419.937→ 76,899.74 total
  • Exercise/Conversion

    Genzyme common stock (GENZ)

    2011-04-04+406.711→ 77,306.451 total
  • Exercise/Conversion

    Genzyme common stock (GENZ)

    2011-04-04+391.993→ 78,104.154 total
  • Exercise/Conversion

    Genzyme common stock (GENZ)

    2011-04-04+314.696→ 79,429.015 total
  • Exercise/Conversion

    Phantom Stock

    2011-04-04−188.58→ 0 total
    From: 2004-09-30Exp: 2034-12-31→ Genzyme common stock (GENZ) (188.58 underlying)
  • Exercise/Conversion

    Phantom Stock

    2011-04-04−224.025→ 0 total
    From: 2006-09-30Exp: 2034-12-31→ Genzyme common stock (GENZ) (224.025 underlying)
  • Exercise/Conversion

    Phantom Stock

    2011-04-04−262.392→ 0 total
    From: 2008-09-30Exp: 2034-12-31→ Genzyme common stock (GENZ) (262.392 underlying)
  • Exercise/Conversion

    Phantom Stock

    2011-04-04−233.401→ 0 total
    From: 2004-12-31Exp: 2034-12-31→ Genzyme common stock (GENZ) (233.401 underlying)
  • Exercise/Conversion

    Genzyme common stock (GENZ)

    2011-04-04+949.906→ 74,482.906 total
  • Exercise/Conversion

    Genzyme common stock (GENZ)

    2011-04-04+430.322→ 76,479.803 total
  • Exercise/Conversion

    Genzyme common stock (GENZ)

    2011-04-04+609.952→ 75,092.858 total
  • Exercise/Conversion

    Genzyme common stock (GENZ)

    2011-04-04+233.401→ 81,300.491 total
  • Exercise/Conversion

    Genzyme common stock (GENZ)

    2011-04-04+445.149→ 76,049.481 total
  • Exercise/Conversion

    Genzyme common stock (GENZ)

    2011-04-04+405.71→ 77,712.161 total
  • Exercise/Conversion

    Genzyme common stock (GENZ)

    2011-04-04+322.9→ 78,795.991 total
  • Exercise/Conversion

    Genzyme common stock (GENZ)

    2011-04-04+511.474→ 75,604.332 total
  • Exercise/Conversion

    Genzyme common stock (GENZ)

    2011-04-04+274.709→ 80,282.974 total
  • Exercise/Conversion

    Genzyme common stock (GENZ)

    2011-04-04+266.952→ 80,549.926 total
  • Exercise/Conversion

    Genzyme common stock (GENZ)

    2011-04-04+262.392→ 80,812.318 total
  • Exercise/Conversion

    Genzyme common stock (GENZ)

    2011-04-04+254.772→ 81,067.09 total
  • Exercise/Conversion

    Genzyme common stock (GENZ)

    2011-04-04+230.137→ 81,530.628 total
  • Exercise/Conversion

    Phantom Stock

    2011-04-04−405.71→ 0 total
    From: 2009-03-31Exp: 2034-12-31→ Genzyme common stock (GENZ) (405.71 underlying)
  • Exercise/Conversion

    Phantom Stock

    2011-04-04−368.937→ 0 total
    From: 2008-06-30Exp: 2034-12-31→ Genzyme common stock (GENZ) (368.937 underlying)
  • Exercise/Conversion

    Phantom Stock

    2011-04-04−430.322→ 0 total
    From: 2009-06-30→ Genzyme common stock (GENZ) (430.322 underlying)
  • Exercise/Conversion

    Phantom Stock

    2011-04-04−949.906→ 0 total
    From: 2010-06-30→ Genzyme common stock (GENZ) (949.906 underlying)
  • Exercise/Conversion

    Phantom Stock

    2011-04-04−175.975→ 0 total
    From: 2005-09-30Exp: 2034-12-31→ Genzyme common stock (GENZ) (175.975 underlying)
  • Exercise/Conversion

    Phantom Stock

    2011-04-04−406.711→ 0 total
    From: 2009-09-30→ Genzyme common stock (GENZ) (406.711 underlying)
  • Exercise/Conversion

    Phantom Stock

    2011-04-04−419.937→ 0 total
    From: 2008-12-31Exp: 2034-12-31→ Genzyme common stock (GENZ) (419.937 underlying)
  • Exercise/Conversion

    Phantom Stock

    2011-04-04−609.952→ 0 total
    From: 2009-12-31→ Genzyme common stock (GENZ) (609.952 underlying)
  • Disposition to Issuer

    Stock Option (right to buy)

    2011-04-04$51.52/sh−7,125$367,080→ 0 total
    Exercise: $51.52Exp: 2020-06-16→ Genzyme common stock (GENZ) (7,125 underlying)
  • Exercise/Conversion

    Genzyme common stock (GENZ)

    2011-04-04+211.121→ 81,965.774 total
  • Exercise/Conversion

    Genzyme common stock (GENZ)

    2011-04-04+188.58→ 82,362.885 total
  • Exercise/Conversion

    Genzyme common stock (GENZ)

    2011-04-04+175.975→ 82,538.86 total
  • Exercise/Conversion

    Phantom Stock

    2011-04-04−314.696→ 0 total
    From: 2008-03-31Exp: 2034-12-31→ Genzyme common stock (GENZ) (314.696 underlying)
  • Exercise/Conversion

    Phantom Stock

    2011-04-04−511.474→ 0 total
    From: 2010-03-31→ Genzyme common stock (GENZ) (511.474 underlying)
  • Exercise/Conversion

    Phantom Stock

    2011-04-04−274.709→ 0 total
    From: 2004-06-30Exp: 2034-12-20→ Genzyme common stock (GENZ) (274.709 underlying)
  • Exercise/Conversion

    Phantom Stock

    2011-04-04−208.531→ 0 total
    From: 2005-06-30Exp: 2034-12-31→ Genzyme common stock (GENZ) (208.531 underlying)
  • Exercise/Conversion

    Phantom Stock

    2011-04-04−266.952→ 0 total
    From: 2006-06-30Exp: 2034-12-31→ Genzyme common stock (GENZ) (266.952 underlying)
  • Exercise/Conversion

    Phantom Stock

    2011-04-04−230.137→ 0 total
    From: 2007-06-30Exp: 2034-12-31→ Genzyme common stock (GENZ) (230.137 underlying)
  • Exercise/Conversion

    Phantom Stock

    2011-04-04−318.328→ 0 total
    From: 2007-09-30Exp: 2034-12-31→ Genzyme common stock (GENZ) (318.328 underlying)
  • Exercise/Conversion

    Phantom Stock

    2011-04-04−292.752→ 0 total
    From: 2005-12-31Exp: 2034-12-31→ Genzyme common stock (GENZ) (292.752 underlying)
  • Exercise/Conversion

    Phantom Stock

    2011-04-04−391.993→ 0 total
    From: 2007-12-31Exp: 2034-12-31→ Genzyme common stock (GENZ) (391.993 underlying)
  • Exercise/Conversion

    Restricted Stock Units

    2011-04-04−2,375→ 0 total
    Exercise: $0.00→ Genzyme common stock (GENZ) (2,375 underlying)
  • Disposition to Issuer

    Stock Option (right to buy)

    2011-04-04$43.90/sh−15,000$658,500→ 0 total
    Exercise: $43.90From: 2005-05-27Exp: 2014-05-27→ Genzyme common stock (GENZ) (15,000 underlying)
Footnotes (3)
  • [F1]The phantom stock acquired under the Genzyme Directors? Deferred Compensation Plan was cancelled at the completion of the sanofi-aventis tender offer and converted into the right to receive a cash payment based on the closing price of Genzyme common stock on the last day it traded. Phantom stock was credited to the Reporting Person?s stock account under the deferred compensation at the end of each fiscal quarter from Apiril 1, 2004 through December 31, 2010, pursuant to the Reporting Person?s plan election and the terms of the plan.
  • [F2]The vested restricted stock units were scheduled to vest on the date of the 2011 annual meeting of shareholders.
  • [F3]This option, which provided for vesting at the next annual meeting of shareholders, was cancelled upon the consummation of the sanofi-aventis tender offer in exchange for a payment representing (A) an amount of cash equal to the excess of $74.00 over the exercise price of the option, multiplied by the total number of shares subject to such options, and (B) one contingent value right (CVR) per cancelled option.

Documents

1 file

Issuer

GENZYME CORP

CIK 0000732485

→
Entity typeother
IncorporatedMA

Related Parties

1
  • filerCIK 0001082257

Filing Metadata

Form type
4
Filed
Apr 5, 8:00 PM ET
Accepted
Apr 6, 8:24 PM ET
Size
108.5 KB
View on SEC.gov